Arcutis Biotherapeutics, Inc. ARQT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s enterprise value?
- Arcutis Biotherapeutics, Inc. (ARQT) reported enterprise value of $3B in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s enterprise value changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s enterprise value increased by 57.0% year-over-year, from $1.91B to $3B.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s enterprise value has grown at a 21.8% compound annual growth rate (CAGR), from $1.35B to $3.63B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.